I was optimistic before we announced the Merlin acquisition and the dilution that went with that.
Not that I necessarily disagree that Merlin was a good idea, but I'm expecting the capex for that to put a short term brake on the SP.
That said, a promising bulk sample result from a new kimberlite, or a restructure of the ownership arrangements should well and truly see them in the money.
LOM as a trade, page-181
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
